Here’s what you should know.
1. A group of angel investors supplemented funding Orthokina received from a Biomedical Catalyst award and an Industrial Challenge award.
2. Orthonika will use the funding to accelerate the implant’s biomechanical testing and to carry out a pre-clinical pilot trial.
3. Orthonika Co-Founder and CEO Mario Alberto Accardi, PhD, said in a release, “This investment demonstrates a strong endorsement of our progress in developing a novel solution for meniscus injury and allows us to cement our network of collaborators and suppliers.”
More articles on orthopedics:
Return to play, patient satisfaction high in active athletes after ACL reconstruction — 5 study insights
Dr. Jeffrey Dugas performs surgery on WWE star Braum Strowman: 4 key notes
University of Pennsylvania, Children’s Hospital of Philadelphia to study youth concussions: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.